| Discipline | Neuroscience |
|---|---|
| Language | English |
| Edited by | Charles Kennedy |
| Publication details | |
| History | 2004-present |
| Publisher | Springer Science+Business Media |
| Frequency | Quarterly |
| Impact factor | 3.5 (2022) |
| Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt  ) | |
| ISO 4 | Purinergic Signal. |
| Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus | |
| CODEN | PSUIA9 |
| ISSN | 1573-9538 (print) 1573-9546 (web) |
| OCLC no. | 57767451 |
| Links | |
Purinergic Signalling is a quarterly peer-reviewed scientific journal covering research on purinergic signalling. It is published by Springer Science+Business Media and its editor-in-chief is Charles Kennedy. The founding editor was Geoffrey Burnstock.
Abstracting and indexing
The journal is abstracted and indexed in:
- Biological Abstracts
- BIOSIS
- Chemical Abstracts Service
- MEDLINE/PubMed
- Science Citation Index Expanded
- Scopus
According to the Journal Citation Reports, it had a 2012 impact factor of 2.635.
References
- "Purinergic Signalling". 2012 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2013.
External links
  | This article about a neuroscience journal is a stub. You can help Misplaced Pages by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |